IMPORTANCE: Evidence that longer-term and exclusive breastfeeding reduces child obesity risk is based on observational studies that are prone to confounding. OBJECTIVE: To investigate effects of an intervention to promote increased duration and exclusivity of breastfeeding on child adiposity and circulating insulin-like growth factor (IGF)-I, which regulates growth. DESIGN, SETTING, AND PARTICIPANTS: Cluster-randomized controlled trial in 31 Belarusian maternity hospitals and their affiliated clinics, randomized into 1 of 2 groups: breastfeeding promotion intervention (n = 16) or usual practices (n = 15). Participants were 17,046 breastfeeding mother-infant pairs enrolled in 1996 and 1997, of whom 13,879 (81.4%) were followed up between January 2008 and December 2010 at a median age of 11.5 years. INTERVENTION: Breastfeeding promotion intervention modeled on the WHO/UNICEF Baby-Friendly Hospital Initiative (World Health Organization/United Nations Children's Fund). MAIN OUTCOME MEASURES: Body mass index (BMI), fat and fat-free mass indices (FMI and FFMI), percent body fat, waist circumference, triceps and subscapular skinfold thicknesses, overweight and obesity, and whole-blood IGF-I. Primary analysis was based on modified intention-to-treat (without imputation), accounting for clustering within hospitals and clinics. RESULTS: The experimental intervention substantially increased breastfeeding duration and exclusivity when compared with the control (43% vs 6% exclusively breastfed at 3 months and 7.9% vs 0.6% at 6 months). Cluster-adjusted mean differences in outcomes at 11.5 years of age between experimental vs control groups were: 0.19 (95% CI, -0.09 to 0.46) for BMI; 0.12 (-0.03 to 0.28) for FMI; 0.04 (-0.11 to 0.18) for FFMI; 0.47% (-0.11% to 1.05%) for percent body fat; 0.30 cm (-1.41 to 2.01) for waist circumference; -0.07 mm (-1.71 to 1.57) for triceps and -0.02 mm (-0.79 to 0.75) for subscapular skinfold thicknesses; and -0.02 standard deviations (-0.12 to 0.08) for IGF-I. The cluster-adjusted odds ratio for overweight/obesity (BMI ≥ 85th vs <85th percentile) was 1.18 (95% CI, 1.01 to 1.39) and for obesity (BMI ≥ 95th vs <85th percentile) was 1.17 (95% CI, 0.97 to 1.41). CONCLUSIONS: AND RELEVANCE Among healthy term infants in Belarus, an intervention that succeeded in improving the duration and exclusivity of breastfeeding did not prevent overweight or obesity, nor did it affect IGF-I levels at age 11.5 years. Breastfeeding has many advantages but population strategies to increase the duration and exclusivity of breastfeeding are unlikely to curb the obesity epidemic. TRIAL REGISTRATION: isrctn.org: ISRCTN37687716; and clinicaltrials.gov: NCT01561612.
RCT Entities:
IMPORTANCE: Evidence that longer-term and exclusive breastfeeding reduces childobesity risk is based on observational studies that are prone to confounding. OBJECTIVE: To investigate effects of an intervention to promote increased duration and exclusivity of breastfeeding on child adiposity and circulating insulin-like growth factor (IGF)-I, which regulates growth. DESIGN, SETTING, AND PARTICIPANTS: Cluster-randomized controlled trial in 31 Belarusian maternity hospitals and their affiliated clinics, randomized into 1 of 2 groups: breastfeeding promotion intervention (n = 16) or usual practices (n = 15). Participants were 17,046 breastfeeding mother-infant pairs enrolled in 1996 and 1997, of whom 13,879 (81.4%) were followed up between January 2008 and December 2010 at a median age of 11.5 years. INTERVENTION: Breastfeeding promotion intervention modeled on the WHO/UNICEF Baby-Friendly Hospital Initiative (World Health Organization/United Nations Children's Fund). MAIN OUTCOME MEASURES: Body mass index (BMI), fat and fat-free mass indices (FMI and FFMI), percent body fat, waist circumference, triceps and subscapular skinfold thicknesses, overweight and obesity, and whole-blood IGF-I. Primary analysis was based on modified intention-to-treat (without imputation), accounting for clustering within hospitals and clinics. RESULTS: The experimental intervention substantially increased breastfeeding duration and exclusivity when compared with the control (43% vs 6% exclusively breastfed at 3 months and 7.9% vs 0.6% at 6 months). Cluster-adjusted mean differences in outcomes at 11.5 years of age between experimental vs control groups were: 0.19 (95% CI, -0.09 to 0.46) for BMI; 0.12 (-0.03 to 0.28) for FMI; 0.04 (-0.11 to 0.18) for FFMI; 0.47% (-0.11% to 1.05%) for percent body fat; 0.30 cm (-1.41 to 2.01) for waist circumference; -0.07 mm (-1.71 to 1.57) for triceps and -0.02 mm (-0.79 to 0.75) for subscapular skinfold thicknesses; and -0.02 standard deviations (-0.12 to 0.08) for IGF-I. The cluster-adjusted odds ratio for overweight/obesity (BMI ≥ 85th vs <85th percentile) was 1.18 (95% CI, 1.01 to 1.39) and for obesity (BMI ≥ 95th vs <85th percentile) was 1.17 (95% CI, 0.97 to 1.41). CONCLUSIONS: AND RELEVANCE Among healthy term infants in Belarus, an intervention that succeeded in improving the duration and exclusivity of breastfeeding did not prevent overweight or obesity, nor did it affect IGF-I levels at age 11.5 years. Breastfeeding has many advantages but population strategies to increase the duration and exclusivity of breastfeeding are unlikely to curb the obesity epidemic. TRIAL REGISTRATION: isrctn.org: ISRCTN37687716; and clinicaltrials.gov: NCT01561612.
Authors: M S Kramer; B Chalmers; E D Hodnett; Z Sevkovskaya; I Dzikovich; S Shapiro; J P Collet; I Vanilovich; I Mezen; T Ducruet; G Shishko; V Zubovich; D Mknuik; E Gluchanina; V Dombrovskiy; A Ustinovitch; T Kot; N Bogdanovich; L Ovchinikova; E Helsing Journal: JAMA Date: 2001 Jan 24-31 Impact factor: 56.272
Authors: Mari-Anne Rowlands; Jeff M P Holly; David Gunnell; Jenny Donovan; J Athene Lane; Freddie Hamdy; David E Neal; Steven Oliver; George Davey Smith; Richard M Martin Journal: Cancer Res Date: 2011-11-21 Impact factor: 12.701
Authors: Christopher G Owen; Richard M Martin; Peter H Whincup; George Davey Smith; Derek G Cook Journal: Pediatrics Date: 2005-05 Impact factor: 7.124
Authors: Anni Larnkjaer; Helga K Ingstrup; Lene Schack-Nielsen; Camilla Hoppe; Christian Mølgaard; Ib M Skovgaard; Anders Juul; Kim F Michaelsen Journal: Growth Horm IGF Res Date: 2008-07-26 Impact factor: 2.372
Authors: Lauren B Guthrie; Emily Oken; Jonathan A C Sterne; Matthew W Gillman; Rita Patel; Konstantin Vilchuck; Natalia Bogdanovich; Michael S Kramer; Richard M Martin Journal: BMC Med Res Methodol Date: 2012-03-13 Impact factor: 4.615
Authors: Lai Ling Hui; Man Ki Kwok; E Anthony S Nelson; So Lun Lee; Gabriel M Leung; C Mary Schooling Journal: Matern Child Nutr Date: 2017-08-04 Impact factor: 3.092
Authors: Emily Oken; Rita Patel; Lauren B Guthrie; Konstantin Vilchuck; Natalia Bogdanovich; Natalia Sergeichick; Tom M Palmer; Michael S Kramer; Richard M Martin Journal: Am J Clin Nutr Date: 2013-08-14 Impact factor: 7.045
Authors: Tiffany L Blake-Lamb; Lindsey M Locks; Meghan E Perkins; Jennifer A Woo Baidal; Erika R Cheng; Elsie M Taveras Journal: Am J Prev Med Date: 2016-02-22 Impact factor: 5.043
Authors: Michael S Kramer; Xun Zhang; Mourad Dahhou; Seungmi Yang; Richard M Martin; Emily Oken; Robert W Platt Journal: Am J Epidemiol Date: 2017-04-01 Impact factor: 4.897
Authors: Krista Casazza; Andrew Brown; Arne Astrup; Fredrik Bertz; Charles Baum; Michelle Bohan Brown; John Dawson; Nefertiti Durant; Gareth Dutton; David A Fields; Kevin R Fontaine; Steven Heymsfield; David Levitsky; Tapan Mehta; Nir Menachemi; P K Newby; Russell Pate; Hollie Raynor; Barbara J Rolls; Bisakha Sen; Daniel L Smith; Diana Thomas; Brian Wansink; David B Allison Journal: Crit Rev Food Sci Nutr Date: 2015 Impact factor: 11.176
Authors: Olukunmi O Balogun; Elizabeth J O'Sullivan; Alison McFadden; Erika Ota; Anna Gavine; Christine D Garner; Mary J Renfrew; Stephen MacGillivray Journal: Cochrane Database Syst Rev Date: 2016-11-09
Authors: Xun Zhang; Kate Tilling; Richard M Martin; Emily Oken; Ashley I Naimi; Izzuddin M Aris; Seungmi Yang; Michael S Kramer Journal: Int J Epidemiol Date: 2019-02-01 Impact factor: 7.196